Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics

Given the need to improve the efficacy of standard-of-care immunotherapy (anti-CTLA-4 + anti-PD-1) in human malignant pleural mesothelioma (hMPM), we thoroughly characterized the immunobiology of the AB12 murine mesothelioma (MM) model, aiming to increase its accuracy in predicting the response of h...

Descripción completa

Detalles Bibliográficos
Autores principales: Stern, Esther, Caruso, Stefano, Meiller, Clément, Mishalian, Inbal, Hirsch, Theo Z., Bayard, Quentin, Tadmor, Carmit T., Wald, Hanna, Jean, Didier, Wald, Ori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846605/
https://www.ncbi.nlm.nih.gov/pubmed/36685577
http://dx.doi.org/10.3389/fimmu.2022.1026185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846605/
https://www.ncbi.nlm.nih.gov/pubmed/36685577
http://dx.doi.org/10.3389/fimmu.2022.1026185

Ejemplares similares